Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Sanofi Consumer Healthcare India Ltd. Share Price
Day's Range
Day's Range
Low
₹4,521.00
High
₹4,676.40
Price Summary
| Previous Close | ₹4,611.90 |
|---|---|
| Day's Range | ₹4,521.00 - ₹4,676.40 |
| Open | ₹4,631.40 |
| 52 Week Range | ₹3,975.00 - ₹5,894.50 |
| Volume | 6,170 |
| Market Cap | ₹0.01 |
| Previous Close | ₹4,507.00 |
|---|---|
| Day's Range | ₹4,507.00 - ₹4,699.80 |
| Open | ₹4,596.85 |
| 52 Week Range | ₹3,950.50 - ₹5,954.00 |
| Volume | 781 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 284.55 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 1.61 |
| Price/Earning (TTM) | 41.56 |
| TTM EPS (₹) | 111.98 |
| P/E Ratio | 62.61 |
| Book Value(₹) | 23.72 |
| PAT Margin (%) | 23.92 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 104.33 |
| Trade Value ( ₹ in Lacs) | 35.20 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 1.61 |
| Price/Earning (TTM) | 41.56 |
| TTM EPS (₹) | 111.98 |
| P/E Ratio | 62.61 |
| Book Value(₹) | 23.72 |
| PAT Margin (%) | 23.92 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 104.33 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1726.0 | 7245.0 |
| Expenses | N/A | N/A |
| PBT | 668.0 | 2468.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 500.0 | 1810.0 |
About Sanofi Consumer Healthcare India Ltd.
| Founded | 2023 |
|---|---|
| Managing Director | Himanshu Bakshi |
| NSE Symbol | SANOFICONR |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,49,251.48 | 1,845.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,242.24 | 6,637.50 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,52,951.96 | 4,380.05 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,191.66 | 8,025.00 | 6,696.50 - 6,696.50 |
| Dr. Reddy's Laboratories Ltd. | 1,06,811.05 | 1,270.10 | 1,143.90 - 1,143.90 |
| Cipla Ltd. | 1,05,391.40 | 1,295.15 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,02,674.68 | 2,240.70 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,01,937.63 | 2,377.45 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,01,003.24 | 1,017.65 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 96,261.37 | 932.00 | 835.50 - 835.50 |
No Records Found
Latest News
Sanofi Consumer Healthcare India informs about disclosures
Sanofi Consumer Healthcare India informs about outcome of board meeting
With reference to its letter dated 23rd April 2026 informing its Board Meeting that was scheduled today. In this regard, Sanofi Consumer Healthcare India has informed that the Board of Directors at its meeting held today, Tuesday, 28th April 2026, considered and approved the Unaudited Financial Results for the quarter ended 31st March 2026. Further, pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), it has enclosed a copy of the Unaudited Financial Results for the quarter ended 31st March 2026, as approved at the aforesaid meeting, along with a copy of the Limited Review Report duly signed by the Statutory Auditors of the Company. Extract of the aforesaid results will be published in the newspapers in the format prescribed under Regulation 47 of the SEBI Listing Regulations. The aforesaid financial results will also be available on the Company's website at https://www.sanofi.com/en/india/consumerhealthcare/investors/financial-results The meeting of Board of Directors commenced at 1:00 pm and concluded at 3:40 pm.
Sanofi Consumer Healthcare India informs about investor meet
Sanofi Consumer Healthcare India submits board meeting intimation
Sanofi Consumer Healthcare India has informed that this is with reference to letter dated 17th February 2026, wherein meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 25th February 2026, to consider and approve the Audited Financial Statements for the Quarter and Financial Year ended 31st December 2025. In furtherance of the above, they informed Sanofi Consumer Healthcare India's Board of Directors may also consider the recommendation of dividend, if any, for the Financial Year ended 31st December 2025 at the aforesaid meeting to be held on Wednesday, 25th February 2026.
The above information is a part of company’s filings submitted to BSE.
BDH Industries submits board meeting intimation
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Sanofi Consumer Healthcare India Ltd. is ₹4,611.90 as of 2026-05-12.
The market capitalisation of Sanofi Consumer Healthcare India Ltd. is ₹10,719.14 as of 2026-05-11.
The 1-year return of Sanofi Consumer Healthcare India Ltd. is 0.00% as of 2026-05-12.
The P/E ratio of Sanofi Consumer Healthcare India Ltd. is 62.61 as of 2026-05-12.
The 52-week high and low of Sanofi Consumer Healthcare India Ltd. are ₹5,894.50 and ₹3,975.00, respectively, as of 2026-05-12.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
